hotspot -WSS

hotspot

author：leisure time 2025-09-03 12:06:54 - browse：868

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： GOP presidential candidates start declaring their loyalty

focus

WSS

'Brian's Song' at 50 still offers lessons about cancer for today

Covid's long

Restaurant meals are packed with calories, and we still keep eating them

The history of OxyContin, told through Purdue Pharma documents

Sage considers ways to reduce costs following FDA rejection

Pharma budget tightening trickles down to Doximity

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

At least 13 dead in Texas as scorching temps continue

Who are the detained American citizens released from prison in Iran?

Virginia high school admissions case could be legal follow

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

United colonoscopy coverage change 'may cost lives,' doctors say

Kansas bar where gunfire wounded 9 last month closes permanently

Moonlake's readout produced a cash windfall. Risks remain

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

'Brian's Song' at 50 still offers lessons about cancer for today

focus

Tuberculosis patients need more than just free medication

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Trump used to be more articulate. What could explain the change?

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Many breast cancer patients receive more radiation than needed

Flash flood warnings continue for parts of Missouri, Illinois

hotspot

focus

focus

hotspot